Relievant Medsystems' Intracept spine procedure earned a positive coverage policy from Anthem Blue Cross Blue Shield, the medtech company said Oct. 3.
Spinal Tech
Premia Spine earned CMS' New Technology Add-on Payment for the TOPS system, the devicemaker said Oct. 2.
Baltimore, Md.-based Johns Hopkins Bayview is adding Globus' Excelsius 3D intraoperative imaging system to its growing fleet of robotic technology, according to a Sept. 27 LinkedIn post.
Here are eight spine medtech products earning FDA approvals and clearances in the third quarter of 2023:
Alphatec's CEO, Patrick Miles, disposed 179,375 company shares for about $12.46 to $13 per share, Seeking Alpha reported Sept. 28.
Advertisement
Centinel Spine's Prodisc C Vivo and C SK cervical disc implants reached 2,500 U.S. cases, the devicemaker said Sept. 28.
CTL Amedica recently landed electronic catalog government contract approval from the U.S. Defense Logistics Agency.
Onward's ARC-IM spinal stimulator was implanted in the first human patient, the devicemaker said Sept. 27.
The FDA gave ZimVie's Mobi-C cervical disc hybrid investigational device exemption, the devicemaker said Sept. 26.
Large spine and orthopedic mergers have closed this year, and smaller device companies have sought to get their own slice of the pie during the third quarter.